{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:53:18Z","timestamp":1759776798869,"version":"3.41.0"},"reference-count":27,"publisher":"Japanese Society of Toxicology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2131\/jts.41.321","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T22:06:43Z","timestamp":1457561203000},"page":"321-328","source":"Crossref","is-referenced-by-count":6,"title":["Establishment of an &lt;i&gt;in silico&lt;\/i&gt; phospholipidosis prediction method using descriptors related to molecular interactions causing phospholipid\u2013compound complex formation"],"prefix":"10.2131","volume":"41","author":[{"given":"Yu","family":"Haranosono","sequence":"first","affiliation":[{"name":"Senju Pharmaceutical Co. Ltd., Pharmacokinetics & Toxicology Research Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Senju Pharmaceutical Co. Ltd., Pharmacokinetics & Toxicology Research Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kurata","sequence":"additional","affiliation":[{"name":"Senju Pharmaceutical Co. Ltd., Pharmacokinetics & Toxicology Research Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Senju Pharmaceutical Co. Ltd., Pharmacokinetics & Toxicology Research Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","unstructured":"Amberg, A., Dorau, M., Thierjung, A., Stole, M., Matter, H., Dietrich, A., Evers, A., Frank, S., Schmidt, F., Karl, J., Schafer, H., Kurz, M. and Czich, A. (2011): Phospholipidosis: validation of an integrated testing strategy from<i> in silico<\/i> models to<i> in vitro<\/i> assay to<i> in vivo<\/i> biomarkers, SOT."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Anderson, N. and Borlak, J. (2006): Drug-induced phospholipidosis. FEBS Lett., <b>580<\/b>, 5533-5540.","DOI":"10.1016\/j.febslet.2006.08.061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Baronas, E.T., Lee, J.W., Alden, C. and Hsieh, F.Y. (2007): Biomarkers to monitor drug-induced phospholipidosis. Toxicol. Appl. Pharmacol., <b>218<\/b>, 72-78.","DOI":"10.1016\/j.taap.2006.10.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Brasseur, R., Carlier, M.B., Laurent, G., Claes, P.J., Vanderhaeghe, H.J., Tulkens, P.M. and Ruysschaert, J.M. (1985): Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities. Biochem. Pharmacol., <b>34<\/b>, 1035-1047.","DOI":"10.1016\/0006-2952(85)90607-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Efron, B. (1979): Bootstrap methods: another look at the jackknife. Ann. Statist., <b>7<\/b>, 1-26.","DOI":"10.1214\/aos\/1176344552"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Fischer, H., Atzpodien, E.A., Csato, M., Doessegger, L., Lenz, B., Schmitt, G. and Singer, T. (2012): <i>In silico<\/i> assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. J. Med. Chem., <b>55<\/b>, 126-139.","DOI":"10.1021\/jm201082a"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fujimura, H., Dekura, E., Kurabe, M., Shimazu, N., Koitabashi, M. and Toriumi, W. (2007): Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. Exp. Toxicol. Pathol., <b>58<\/b>, 375-382.","DOI":"10.1016\/j.etp.2007.01.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Goracci, L., Buratta, S., Urbanelli, L., Ferrara, G., Di Guida, R., Emilliani, C. and Cross, S. (2015): Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach. Eur. J. Med. Chem., <b>92<\/b>, 49-63.","DOI":"10.1016\/j.ejmech.2014.12.028"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Halliwell, W.H. (1997): Cationic Amphiphilic drug-induced phospholipidosis. Toxicol. Pathol., <b>25<\/b>, 53-60.","DOI":"10.1177\/019262339702500111"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hanumeqowda, U.M., Wenke, G., Requeiro-Ren, A., Yordanova, R., Corradi, J.P. and Adams, S.P. (2010): Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds. Chem. Res. Toxicol., <b>23<\/b>, 749-755.","DOI":"10.1021\/tx9003825"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Haranosono, Y., Kurata, M. and Sakaki, H. (2014): Establishment of an <i>in silico<\/i> phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction. J. Toxicol. Sci., <b>39<\/b>, 655-664.","DOI":"10.2131\/jts.39.655"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kacew, S. (1985): Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity. J. Pharamacol. Exp. Ther., <b>232<\/b>, 239-243.","DOI":"10.1016\/S0022-3565(25)20091-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Katagiri, T. and Uneyama, K. (2001): A correlation between boiling points and refractive indices of organic compounds: a possible role of fluorine atoms in intermolecular interaction. Bull. Chem. Soc. Jpn., <b>74<\/b>, 1409-1410.","DOI":"10.1246\/bcsj.74.1409"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kasahara, T., Tomita, K., Murano, H., Harada, T., Tsubakimoto, K., Ogihara, T., Ohnishi, S. and Kakinuma, C. (2006): Establishment of an <i>in vitro<\/i> high-throughput screening assay for detecting phospholipidosis-inducing potential. Toxicol. Sci., <b>90<\/b>, 133-141.","DOI":"10.1093\/toxsci\/kfj067"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kikkawa, R., Yamamoto, T., Fukushima, T., Yamada, H. and Horii, I. (2005): Investigation of a hepatotoxicity screening system in primary cell cultures -\u201cwhat biomarkers would need to be addressed to estimate toxicity in conventional and new approaches?\u201d J. Toxicol. Sci., <b>30<\/b>, 61-72.","DOI":"10.2131\/jts.30.61"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lowe, R., Mussa, H.Y., Nigsch, F., Glen, R.C. and Mitchell, J.B. (2012): Predicting the mechanism of phospholipidosis. J. Cheminform., <b>4<\/b>, 2.","DOI":"10.1186\/1758-2946-4-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Minagawa, T., Nakano, K., Furuta, S., Iwase, T., Takekawa, K., Minato, K., Koga, T., Sato, T., Kawashima, K., Kurahashi, Y., Onodera, H., Naito, S. and Nakamura, K. (2012): Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop. J. Toxicol. Sci., <b>37<\/b>, 667-673.","DOI":"10.2131\/jts.37.667"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Naito, S., Furuta, S., Yoshida, T., Kitada, M., Fueli, O., Unno, T., Ohno, Y., Onodera, H., Kawamura, N., Kurokawa, M., Sagami, F., Shinoda, K., Nakazawa, T. and Yamazaki, T. (2007): Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals. J. Toxicol. Sci., <b>32<\/b>, 329-341.","DOI":"10.2131\/jts.32.329"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Nioi, P., Perry, B.K., Wang, E.J., Gu, Y.Z. and Snyder, R.D. (2007):<i> In vitro<\/i> detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol. Sci., <b>99<\/b>, 162-173.","DOI":"10.1093\/toxsci\/kfm157"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Park, S., Choi, Y.J. and Lee, B.H. (2012): <i>In vitro<\/i> validation of drug-induced phospholipidosis. J. Toxicol. Sci., <b>37<\/b>, 261-267.","DOI":"10.2131\/jts.37.261"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Pelletier, D.J., Gehlhaar, D., Tilloy-Ellul, A., Johnson, T.O. and Greene, N. (2007): Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential. J. Chem. Inf. Model., <b>47<\/b>, 1196-1205.","DOI":"10.1021\/ci6004542"},{"key":"22","unstructured":"Pleoman, J.P., Kelder, J., Hafmans, T., van de Sandt, H., van Burgsteden, J.A., Salemink, P.J. and van Esch, E. (2004): Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines. Exp. Toxic. Pathol., <b>55<\/b>, 347-355."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sawada, H., Takami, K. and Asahi, S. (2005): A Toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel<i> in vitro<\/i> screening system. Toxicol. Sci., <b>83<\/b>, 282-292.","DOI":"10.1093\/toxsci\/kfh264"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sun, H., Xia, M., Shahane, S.A., Jadhav, A., Austin, C.P. and Huang, R. (2013): Are hERG channel blockers also phospholipidosis inducers? Bioorg. Med. Chem. Lett., <b>23<\/b>, 4587-4590.","DOI":"10.1016\/j.bmcl.2013.06.034"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Tomizawa, K., Sugano, K., Yamada, H. and Horii, I. (2006): Physicochemical and cell-based approach for early screening of phos pholipidosis-inducing potential. J. Toxicol. Sci., <b>31<\/b>, 315-324.","DOI":"10.2131\/jts.31.315"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Vanagas, G. (2004): Receiver operating characteristic curves and comparison of cardiac surgery risk stratification systems. Interact. Cardiovasc. Thorac. Surg., <b>3<\/b>, 319-322.","DOI":"10.1016\/j.icvts.2004.01.008"},{"key":"27","unstructured":"Yuta, K. (2010): Generation two-class classification model for prediction chemical toxicity. US Patent, <b>7<\/b>, 725, 413 B2."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/2\/41_321\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:22:16Z","timestamp":1748802136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/2\/41_321\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.41.321","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"type":"print","value":"0388-1350"},{"type":"electronic","value":"1880-3989"}],"subject":[],"published":{"date-parts":[[2016]]}}}